These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36163675)

  • 1. The economic burden of TB faced by patients and affected families in Papua New Guinea.
    Aia P; Viney K; Kal M; Kisomb J; Yasi R; Wangchuk LZ; Islam T; Jadambaa N; Rehan R; Nishikori N; Labelle S; Ershova J
    Int J Tuberc Lung Dis; 2022 Oct; 26(10):934-941. PubMed ID: 36163675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG
    PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
    Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
    BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
    PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
    Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
    BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
    Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
    PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
    Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
    Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
    Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
    Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China: A cross-sectional study.
    Wang Y; McNeil EB; Huang Z; Chen L; Lu X; Wang C; Chen H; Chongsuvivatwong V
    Medicine (Baltimore); 2020 Jul; 99(28):e21023. PubMed ID: 32664107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands.
    Viney K; Itogo N; Yamanaka T; Jebeniani R; Hazarika A; Morishita F; Nishikiori N; Nery SV
    BMC Public Health; 2021 Oct; 21(1):1928. PubMed ID: 34688266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
    Yang T; Chen T; Che Y; Chen Q; Bo D
    BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines.
    Florentino JL; Arao RML; Garfin AMC; Gaviola DMG; Tan CR; Yadav RP; Hiatt T; Morishita F; Siroka A; Yamanaka T; Nishikiori N
    PLoS One; 2022; 17(2):e0264689. PubMed ID: 35226705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey.
    Aia P; Kal M; Lavu E; John LN; Johnson K; Coulter C; Ershova J; Tosas O; Zignol M; Ahmadova S; Islam T
    PLoS One; 2016; 11(3):e0149806. PubMed ID: 27003160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring Catastrophic Costs Due to Tuberculosis in Myanmar.
    Aung ST; Thu A; Aung HL; Thu M
    Trop Med Infect Dis; 2021 Jul; 6(3):. PubMed ID: 34287379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies.
    Ghazy RM; Sallam M; Ashmawy R; Elzorkany AM; Reyad OA; Hamdy NA; Khedr H; Mosallam RA
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis.
    Assefa DG; Dememew ZG; Zeleke ED; Manyazewal T; Bedru A
    BMC Public Health; 2024 Jan; 24(1):260. PubMed ID: 38254019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.